Flibanserin, marketed under the brand name Addyi, is a medication approved by the U.S. Food and Drug Administration (FDA) to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. It's available in a 100 mg tablet form. HSDD is characterized by a persistent lack of sexual desire that causes distress or interpersonal difficulties. Flibanserin works by affecting neurotransmitters in the brain to help increase sexual desire. https://www.genericday.com/fliban-100-mg.html